Emcure Pharma

Rediff.com » News » Emcure Pharma

News for Emcure Pharma

News
Business

Govt approves 2 new vaccines, Covid drug for emergency use

Union Health Minister Mansukh Mandaviya on Tuesday said that the Central Drugs Standard Control Organisation (CDSCO) has approved the Serum Institute of India's COVID-19 vaccine Covovax, Biological......

CDSCO panel recommends anti-Covid pill Molnupiravir for emergency use

An expert panel of the Central Drugs Standard Control Organisation on Monday recommended granting permission to manufacture and market anti-Covid pill Molnupiravir for restricted emergency use for......

5 more manufacturers to produce black fungus drug: Govt

The Union health ministry on Friday said license has been given to five more manufacturers for production of Amphotericin-B, used in the treatment of black fungus, and they will start producing......

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'Mmolnupiravir', which is being studied for the treatment of Covid-19, with......

How Much Have MFs Invested In HDFC Bank?

With a deployment of Rs 2,720 crore in July, MFs' total investment in HDFC Bank in calendar year 2024 (till now) surged to Rs 48,820 crore. Photograph: Anushree Fadnavis/Reuters Mutual......

MNCs look towards India for a booster dose

In recent months, several pharma multinational corporations (MNCs) are increasingly turning to Indian companies to expand market reach in the country’s pharmaceuticals sector. Illustration:......

4 IPOs to watch out for in 2022

Once stability returns to the secondary market, companies that have obtained approval from Sebi will start tapping the market. Sundar Sethuraman & Samie Modak report. Illustration: Dominic......

30 cos may float IPOs in Oct-Nov to mop up Rs 45,000 cr

Hectic fundraising through initial public offerings (IPOs) is expected in October-November, with at least 30 companies are looking to collectively raise over Rs 45,000 crore through initial......

Prices of key diabetes, cancer drugs may drop by 25%

A recent report has suggested that future patent expires in the cardiac and anti-diabetes space would form a good opportunity for smaller firms, given their franchise in these segments. The next......

Rediff News

Emcure Pharma

News for Emcure Pharma

Govt approves 2 new vaccines, Covid drug for emergency use

CDSCO panel recommends anti-Covid pill Molnupiravir for emergency use

5 more manufacturers to produce black fungus drug: Govt

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

How Much Have MFs Invested In HDFC Bank?

MNCs look towards India for a booster dose

4 IPOs to watch out for in 2022

30 cos may float IPOs in Oct-Nov to mop up Rs 45,000 cr

Prices of key diabetes, cancer drugs may drop by 25%

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS